Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis

作者：Tiantian Yang, Wanru Luo, Jie Yu, Huiping Zhang, Meichun Hu, Jun Tian · 发表于：Frontiers in Immunology · 年份：2024 · DOI：10.3389/fimmu.2024.1481296 · 被引用次数：20 · 研究领域：Ferroptosis and cancer prognosis、Immune cells in cancer、RNA modifications and cancer

As an immune-related tumor type, bladder cancer has been attracting much attention in the study of its markers. In recent years, researchers have made rapid progress in the study of immune-related markers for bladder cancer. Studies have shown that immune-related markers play an important role in the diagnosis, prognosis assessment and treatment of bladder cancer. In addition, the detection of immune-related markers can also be used to evaluate the efficacy of immunotherapy and predict the treatment response of patients. Therefore, in depth study of the expression of immune-related markers in bladder cancer and their application in the clinic is of great significance and is expected to provide new breakthroughs for individualized treatment of bladder cancer. Future studies will focus more on how to detect immune-related markers with low cost and high accuracy, as well as develop new immunotherapeutic strategies to bring better therapeutic outcomes to bladder cancer patients.